Supplementary Tables – Biomarker subset analysis of a Phase IIIb, open-label study of afatinib in EGFR TKI-naïve patients with EGFRm+ NSCLC
收藏数据链接：
官方服务：
资源简介：
Supplementary Table 1. TRAEs occurring in ≥10% of patients. Supplementary Table 2. Subgroup analysis of TTSP and PFS in biomarker group.
创建时间：
2022-02-04
